Moderna, Inc. vs Oxurion NV
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $3 M for Oxurion NV, 30044 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Oxurion NV). Oxurion NV's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $0 M for Oxurion NV in the year to December 2023.
- Both made a net loss: $2.8 B for Moderna, Inc. and $20 M for Oxurion NV.
- Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -7321.4% for Oxurion NV.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #275 in the world | Oxurion NV OXUR.BR |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇧🇪 Belgium |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | — |
| Size | ||
| Market cap | $90.1 B | $3 M* |
| Revenue | $1.9 B | $0 M |
| Net income | $-2.8 B | $-21 M▲ best |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9% | — |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
Questions and answers#
Which is bigger, Moderna, Inc. or Oxurion NV?
Moderna, Inc. is the larger company by market value: $90.1 B against $3 M for Oxurion NV, 30044 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Oxurion NV). Oxurion NV's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Moderna, Inc. or Oxurion NV?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $0 M for Oxurion NV in the year to December 2023. Both made a net loss: $2.8 B for Moderna, Inc. and $20 M for Oxurion NV.
Which is more profitable, Moderna, Inc. or Oxurion NV?
Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -7321.4% for Oxurion NV.